share_log

羚锐制药(600285.SH):盐酸二甲双胍缓释片获得药品注册证书

Ling Rui Pharmaceutical (600285.SH): Metformin hydrochloride extended-release tablets obtained drug registration certificate

Gelonghui Finance ·  May 10 05:21

Gelonghui, May 10, 丨 Ling Rui Pharmaceutical (600285.SH) announced that the company recently received the “Drug Registration Certificate” for metformin hydrochloride extended-release tablets approved and issued by the State Drug Administration. Metformin hydrochloride sustained-release tablets are biguanide hypoglycemic agents, which can reduce the amount of glucose produced by the liver and absorption of glucose by the intestines, and increase insulin sensitivity and lower basal and post-meal blood sugar by increasing the intake and utilization of peripheral glucose.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment